Vincristyra 1mg Inj

Vincristyra 1mg Inj is a strong anticancer medicine with Vincristine Sulphate as an active ingredient which is a chemotherapy drug.

It is prescribed to treat various types of cancer, such as breast cancer, multiple myeloma, blood cancer, bone cancer, pancreatic cancer, kidney cancer, non-small cell lung cancer, and lymphomas. This injection acts by blocking the microtubule structure within the cell to control the progression of cancer.

This injection should be administered into the vein by a doctor or experienced nurse. Don't self- administer the injection.

​

• Breast cancer
• Multiple myeloma
• Blood cancer
• Bone cancer
• Pancreatic cancer
• Kidney cancer
• Non-small cell lung cancer
• Lymphomas

Vincristyra 1mg Inj is a strong anticancer medicine that may show certain adverse while manageable impact on the body during the treatment. As these effects resolve on their own without any special medical attention. However, if you ever experience serious or unusual side effects contact your healthcare professional immediately.

Some common side effects include:

• Hair loss
• Peripheral neuropathy (tingling and numbness of feet and hand)
• Constipation

• Vinozest 50mg Injection is a prescription-based anticancer drug. It is advised to take this injection after consulting your healthcare expert.
• This medicine should be given intravenously by an experienced nurse or doctor. Please do not self-administer. Doctor determine the dosage and duration of the drug as per the stage & type of cancer, and overall health condition of the patient.

• Vincristyra 1mg Inj is a strong anticancer medicine with Vincristine Sulphate as an active ingredient which is a chemotherapy drug. It acts as a microtubule targeting drug to inhibit mitosis as a result it work by inhibiting the microtubule structure within the cell.
• As microtubule structure promotes cancer cell growth and multiplication and inhibition of these structures by this drug slows the growth and multiplication of cancer cells.​
  

• Thakkar, H. P., Baser, A. K., Parmar, M. P., Patel, K. H., & Ramachandra Murthy, R. (2012). Vincristine-sulphate–loaded liposome-templated calcium phosphate nanoshell as potential tumor-targeting delivery system. Journal of Liposome Research, 22(2), 139-147.  https://pubmed.ncbi.nlm.nih.gov/22149643/      
• Writing Committee. (1963). VINCRISTINE (LEUROCRISTINE) SULFATE IN THE TREATMENT OF CHILDREN WITH METASTATIC WILMS'TUMOR. Pediatrics, 32(5), 880-887. https://pubmed.ncbi.nlm.nih.gov/14075630/
• Sethi, V. S., Jackson Jr, D. V., White, D. R., Richards, F., Stuart, J. J., Muss, H. B., ... & Spurr, C. L. (1981). Pharmacokinetics of vincristine sulfate in adult cancer patients. Cancer research, 41(9_Part_1), 3551-3555. https://pubmed.ncbi.nlm.nih.gov/7260915/
• Tella, M. A., Ajala, O. O., & Taiwo, V. O. (2004). Complete regression of transmissible venereal tumor (TVT) in Nigerian mongrel dogs with vincristine sulphate chemotherapy. African Journal of Biomedical Research, 7(3).
• Writing Committee. (1963). VINCRISTINE (LEUROCRISTINE) SULFATE IN THE TREATMENT OF CHILDREN WITH METASTATIC WILMS'TUMOR. Pediatrics, 32(5), 880-887. https://pubmed.ncbi.nlm.nih.gov/14075630/